Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Dominique S. Michaud

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-8107-3011; OpenAlex author ID A5062350265; NIH RePORTER profile ID 7899116. Sources: OpenAlex.

Their work

Papers
31 (first author 3, last author 4)
Trials
0
Grants
3
Labs led
2
Collaborators
82
Papers, trials and grants by year

2011: 4 papers, 1 grant · 2012: 7 papers · 2013: 5 papers · 2014: 1 paper · 2015: 1 grant · 2016: 2 papers · 2017: none · 2018: 1 grant · 2019: 4 papers · 2020: 3 papers · 2021: 3 papers · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 31

  1. Are people with family history of pancreatic cancer enriched with genetic propensity for diabetes mellitus? Co-author DOI 10.21037/ace-2025-11↗
  2. The oral microbiome in relation to pancreatic cancer risk in African Americans. Co-author DOI 10.1038/s41416-021-01578-5↗
  3. DNA methylation ageing clocks and pancreatic cancer risk: pooled analysis of three prospective nested case-control studies. Last author DOI 10.1080/15592294.2020.1861401↗
  4. Comparisons of oral, intestinal, and pancreatic bacterial microbiomes in patients with pancreatic cancer and other gastrointestinal diseases. Last author DOI 10.1080/20002297.2021.1887680↗
  5. Integrating Genome and Methylome Data to Identify Candidate DNA Methylation Biomarkers for Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-21-0400↗
  6. Epigenome-Wide Association Study Using Prediagnostic Bloods Identifies New Genomic Regions Associated With Pancreatic Cancer Risk. Co-author DOI 10.1093/jncics/pkaa041↗
  7. DNA Methylation-Derived Immune Cell Profiles, CpG Markers of Inflammation, and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0378↗
  8. Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study. Co-author DOI 10.3389/fonc.2020.00263↗
  9. Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort. Co-author DOI 10.1016/j.envres.2018.11.027↗
  10. The Microbiomes of Pancreatic and Duodenum Tissue Overlap and Are Highly Subject Specific but Differ between Pancreatic Cancer and Noncancer Subjects. Last author DOI 10.1158/1055-9965.epi-18-0542↗
  11. Oral Health in Relation to Pancreatic Cancer Risk in African American Women. First author DOI 10.1158/1055-9965.epi-18-1053↗
  12. Chronic inflammation markers are associated with risk of pancreatic cancer in the Swedish AMORIS cohort study. First author DOI 10.1186/s12885-019-6082-6↗
  13. Obesity and Pancreatic Cancer. Co-author DOI 10.1007/978-3-319-42542-9_6↗
  14. Sweet-beverage consumption and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Co-author DOI 10.3945/ajcn.116.130963↗
  15. Microbiota, oral microbiome, and pancreatic cancer. Co-author DOI 10.1097/ppo.0000000000000046↗
  16. Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and… Co-author DOI 10.1002/ijc.27875↗
  17. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Co-author DOI 10.1007/s10552-012-0078-8↗
  18. Intake of coffee, decaffeinated coffee, or tea does not affect risk for pancreatic cancer: results from the European Prospective Investigation into Nutrition a… Co-author DOI 10.1016/j.cgh.2013.05.029↗
  19. Role of bacterial infections in pancreatic cancer. Co-author DOI 10.1093/carcin/bgt249↗
  20. Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study. Co-author DOI 10.1136/gutjnl-2012-303006↗
  21. The association of circulating adiponectin levels with pancreatic cancer risk: a study within the prospective EPIC cohort. Co-author DOI 10.1002/ijc.26244↗
  22. Plasma cotinine levels and pancreatic cancer in the EPIC cohort study. Co-author DOI 10.1002/ijc.26452↗
  23. Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Co-author DOI 10.1002/ijc.27547↗
  24. Inflammation marker and risk of pancreatic cancer: a nested case-control study within the EPIC cohort. Co-author DOI 10.1038/bjc.2012.172↗
  25. Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1038/bjc.2012.19↗
  26. Environmental tobacco smoke and the risk of pancreatic cancer among non-smokers: a meta-analysis. Last author DOI 10.1136/oemed-2012-100844↗
  27. Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-11-0836↗
  28. Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into … Co-author DOI 10.1007/s00125-011-2316-0↗
  29. A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition. Co-author DOI 10.1016/j.ejca.2011.02.007↗
  30. Folate intake and risk of pancreatic cancer: pooled analysis of prospective cohort studies. First author DOI 10.1093/jnci/djr431↗
  31. Dietary insulin load, dietary insulin index, and risk of pancreatic cancer. Co-author DOI 10.3945/ajcn.110.011205↗

Grants 3

  1. Prospective immune profiling using methylation markers and pancreatic cancer risk R01CA207110↗
  2. Microbiomes in Human Pancreatic Cancer R01CA166150↗
  3. SEROLOGICAL MARKERS OF PERIODONTAL DISEASE AND PANCREATIC CANCER RISK R21CA139193↗

Closest collaborators

The 25 strongest of 82 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Karl T. Kelsey · 5 shared papers, 2019–2021 · strength 0.60
  2. Elizabeth A. Platz · 1 shared paper, 2026 · strength 0.39
  3. Albert Ekow Orhin · 1 shared paper, 2026 · strength 0.39
  4. Simon Egyin · 1 shared paper, 2026 · strength 0.39
  5. Mei Chun Chung · 3 shared papers, 2019–2021 · strength 0.36
  6. Karl Timothy Kelsey · 1 shared grant, 2018 · strength 0.34
  7. Jacques Izard · 4 shared papers, 2013–2021 · strength 0.33
  8. Jacques G. Izard · 2 shared grants, 2011–2015 · strength 0.32
  9. Esther Molina‐Montes · 11 shared papers, 2011–2020 · strength 0.32
  10. Julie R Palmer · 2 shared papers, 2019–2022 · strength 0.27
  11. Hanna Gerlovin · 2 shared papers, 2019–2022 · strength 0.27
  12. Xiao‐Ou Shu · 3 shared papers, 2013–2022 · strength 0.26
  13. Eric J. Duell · 12 shared papers, 2011–2016 · strength 0.25
  14. Jirong Long · 2 shared papers, 2021–2022 · strength 0.24
  15. Qiuyin Cai · 2 shared papers, 2021–2022 · strength 0.24
  16. Erika del Castillo · 2 shared papers, 2019–2021 · strength 0.22
  17. H. Bas Bueno-de-Mesquita · 10 shared papers, 2011–2016 · strength 0.21
  18. Elio Ríboli · 10 shared papers, 2011–2016 · strength 0.21
  19. Brian Matthew Wolpin · 4 shared papers, 2011–2022 · strength 0.21
  20. Malin Sund · 10 shared papers, 2011–2013 · strength 0.19
  21. Weimin Ye · 10 shared papers, 2011–2013 · strength 0.19
  22. Sam Sollie · 2 shared papers, 2019–2020 · strength 0.19
  23. Mieke Van Hemelrijck · 2 shared papers, 2019–2020 · strength 0.19
  24. Debashis Sarker · 2 shared papers, 2019–2020 · strength 0.19
  25. Aida Santaolalla · 2 shared papers, 2019–2020 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.